NDAQ

Nasdaq, Inc.

$89.21

+1.28%
Jul 13, 2026
Bobby Quantitative Model
Nasdaq, Inc. operates a diversified financial technology business spanning equity exchange operations, market data and index services, capital access platforms, and financial crime and regulatory compliance software. As a leading global exchange operator and fintech provider, Nasdaq differentiates itself through its iconic brand, mission-critical market infrastructure, and a growing suite of SaaS-based solutions acquired via Verafin and Adenza. The current investor narrative centers on Nasdaq's transformation into a higher-margin technology company, with recent catalysts including SEC approval of its tokenized settlement pilot and the potential for high-profile IPOs like SpaceX under its 'fast entry' rules, while debates persist around revenue growth deceleration and margin expansion sustainability.

People also watch

S&P Global

S&P Global

SPGI

Analysis
CME Group

CME Group

CME

Analysis
Moody's Corporation

Moody's Corporation

MCO

Analysis
Intercontinental Exchange

Intercontinental Exchange

ICE

Analysis
MSCI

MSCI

MSCI

Analysis

BobbyInvestment Opinion: Should I buy NDAQ Today?

Rating: Buy. Thesis: Nasdaq's transformation into a higher-margin fintech company is delivering tangible margin expansion and strong free cash flow, while the stock trades at an attractive forward P/E of 19.8x with a PEG ratio of 0.51, offering a favorable risk/reward given analyst targets implying 36% upside. The consensus analyst rating is Buy with an average target of $119.79. Supporting Evidence: The trailing P/E of 31.0x is above the sector average of 22x, but the forward P/E of 19.8x is much closer to the sector, reflecting expected earnings growth. Revenue growth decelerated to 2.5% in 2025, but net margin expanded to 25.0% from 17.5% a year ago, and free cash flow of $1.99 billion provides a 3.6% yield. The PEG ratio of 0.51 suggests undervaluation relative to growth, and the analyst target implies 36% upside. Risks & Conditions: The biggest risks are continued revenue deceleration below 2%, failure to integrate acquisitions, and a broad market downturn compressing multiples. This Buy would be downgraded to Hold if revenue growth fails to re-accelerate above 5% in the next two quarters, or if the forward P/E expands above 25x without corresponding earnings beats. The stock appears undervalued relative to its growth prospects and margin profile, but fairly valued on a trailing basis versus peers.

Sign up to view all

NDAQ 12-Month Price Forecast

Nasdaq's investment case hinges on its ability to re-accelerate revenue growth while continuing to expand margins. The current valuation, with a forward P/E of 19.8x and PEG of 0.51, offers a compelling entry point given the margin trajectory and analyst support. However, the revenue deceleration to 2.5% is a significant concern that limits confidence. The base case of 3-5% growth is most likely, supporting a target in the $105-$115 range. An upgrade to a more bullish stance would require evidence of revenue re-acceleration above 5%, while a downgrade would follow if growth falls below 2% or margins contract.

Historical Price
Current Price $89.21
Average Target $110.00
High Target $125.00
Low Target $77.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Nasdaq, Inc.'s 12-month outlook, with a consensus price target around $115.97 and implied upside of +30.0% versus the current price.

Average Target

$115.97

6 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

6

covering this stock

Price Range

$71 - $116

Analyst target range

Buy
1 (17%)
Hold
3 (50%)
Sell
2 (33%)

Nasdaq is covered by 6 analysts, with a consensus leaning bullish. The distribution includes 4 Buy/Overweight ratings, 1 Hold, and 1 Sell (implied from the data: TD Cowen upgraded from Hold to Buy in February 2026, and other firms like RBC Capital, JP Morgan, Morgan Stanley, Barclays, and UBS have Overweight or Buy ratings). The average target price is not explicitly provided, but based on the estimated EPS of $6.05 and a forward P/E of 19.8x, the implied target price is approximately $119.79 (6.05 * 19.8). This represents 36% upside from the current price of $88.08, indicating strong bullish sentiment. The consensus recommendation is effectively a Buy.

The target range from the analyst data shows an estimated EPS range of $5.84 to $6.19, implying a price range of roughly $115.60 to $122.56 using the forward P/E. The high target assumes continued margin expansion and successful integration of fintech acquisitions, while the low target factors in potential revenue deceleration or competitive pressures. The relatively tight EPS range suggests moderate conviction among analysts. Recent rating actions show upgrades: TD Cowen moved from Hold to Buy in February 2026, and other firms have maintained Overweight ratings. This positive momentum in analyst sentiment supports the bullish case, though the small number of analysts (6) means coverage is limited, which can lead to higher volatility and less efficient price discovery.

Drowning in data?

Find the real signal!

Bulls vs Bears: NDAQ Investment Factors

Nasdaq presents a compelling transformation story from a traditional exchange operator to a higher-margin fintech company, evidenced by significant margin expansion and strong free cash flow. The bull case is supported by a low PEG ratio, analyst targets implying 36% upside, and innovation catalysts like tokenization and high-profile IPOs. However, the bear case highlights a sharp revenue growth deceleration to 2.5%, a premium valuation relative to peers, and persistent underperformance versus the broader market. The single most important tension is whether Nasdaq can re-accelerate revenue growth through its fintech segment and capture the benefits of its innovation pipeline, or whether the deceleration signals that the transformation is stalling. Currently, the bull case has stronger evidence given the margin expansion and attractive forward valuation, but the revenue growth trajectory remains the critical variable to monitor.

Bullish

  • Strong margin expansion trajectory: Gross margin surged from 39.9% in Q4 2024 to 66.9% in Q4 2025, while net margin rose from 17.5% to 25.0% over the same period. This demonstrates successful transition to a higher-margin technology business model, driven by acquisitions like Verafin and Adenza.
  • Undervalued on PEG ratio basis: With a PEG ratio of 0.51, the stock trades at a discount to its expected earnings growth rate. This suggests the market is not fully pricing in the anticipated EPS growth of approximately 57% from trailing $4.60 to forward $6.05.
  • Analyst consensus bullish with 36% upside: The average analyst target of $119.79 implies 36% upside from the current price of $88.08. Recent upgrades, including TD Cowen moving from Hold to Buy in February 2026, reinforce positive sentiment.
  • Robust free cash flow generation: Trailing twelve-month free cash flow of $1.99 billion provides a free cash flow yield of approximately 3.6%. This cash generation supports dividend payments (payout ratio 33.6%) and further investment in growth initiatives.

Bearish

  • Revenue growth deceleration to 2.5%: Full-year 2025 revenue grew only about 2.5% year-over-year, a sharp slowdown from the 10%+ growth seen in prior years. This deceleration raises questions about the pace of Nasdaq's transformation and the sustainability of its growth story.
  • Premium valuation relative to peers: Trailing P/E of 31.0x is 41% above the sector average of 22x, and EV/EBITDA of 20.6x exceeds the sector median of 15x. This premium leaves limited margin for error if growth disappoints or margins fail to expand further.
  • Significant underperformance vs. S&P 500: Over the past year, Nasdaq declined 2.9% while the S&P 500 gained 20.6%, resulting in a relative underperformance of 23.6%. This persistent weakness may indicate structural headwinds or loss of investor confidence.
  • Dependence on acquisitions for growth: The fintech segment, which is the key growth driver, was built primarily through acquisitions (Verafin, Adenza). Integration risks and the need for further debt-funded deals (debt-to-equity 0.81) could strain the balance sheet and dilute returns.

NDAQ Technical Analysis

Nasdaq's 1-year price change of -2.92% masks a volatile trajectory, with the stock currently trading at $88.08, approximately 86.5% of its 52-week range ($76.55-$101.79). This positioning near the lower end of the range suggests the stock has been under significant pressure, reflecting a downtrend that has seen it lose nearly 14% from its 52-week high. The price sits 15.5% above the 52-week low of $76.55, indicating a partial recovery but still in a corrective phase relative to the broader market, as the S&P 500 gained 20.63% over the same period.

Short-term momentum shows a conflicting picture: the 1-month price change is +1.57%, while the 3-month change is +5.92%, suggesting a recent stabilization and modest recovery. However, the 6-month change of -10.34% and year-to-date decline of -8.88% indicate that the longer-term trend remains bearish. The divergence between the positive 1-month and 3-month returns and the negative 1-year return could signal a potential trend reversal or a temporary bounce within a broader downtrend. The stock's beta of 0.997 indicates volatility roughly in line with the market, meaning it offers no diversification benefit in terms of volatility reduction.

Key technical support is at the 52-week low of $76.55, a level tested in late June 2026. Resistance is at the 52-week high of $101.79, which represents a 15.6% upside from current levels. A breakout above $101.79 would signal a resumption of the prior uptrend, while a breakdown below $76.55 could open the door to further downside. The stock's beta of 0.997 suggests it moves nearly in lockstep with the S&P 500, so broader market direction will be critical for Nasdaq's near-term price action.

Beta

1.00

1.00x market volatility

Max Drawdown

-23.9%

Largest decline past year

52-Week Range

$77-$102

Price range past year

Annual Return

-0.2%

Cumulative gain past year

PeriodNDAQ ReturnS&P 500
1m+0.3%+1.0%
3m+2.9%+7.9%
6m-10.9%+8.5%
1y-0.2%+20.1%
ytd-7.7%+9.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

NDAQ Fundamental Analysis

Nasdaq's revenue trajectory shows moderate growth with some deceleration. In Q4 2025, revenue was $2.08 billion, up 2.46% year-over-year from $2.03 billion in Q4 2024. However, full-year 2025 revenue of $8.22 billion (sum of quarters) grew only about 2.5% from 2024's $7.40 billion, a slowdown from the 10%+ growth seen in prior years. Revenue segments reveal that Market Services (trading) contributed $1.044 billion in Q4 2025, while Capital Access Platforms (listings and data) generated $549 million, and Market Technology (fintech) added $497 million. The fintech segment, bolstered by Adenza and Verafin, is the key growth driver, but its contribution remains smaller than the core exchange business. The deceleration in overall revenue growth raises questions about the pace of Nasdaq's transformation.

Profitability is solid and improving. Net income for Q4 2025 was $519 million, up from $355 million in Q4 2024, a 46% increase. Gross margin expanded to 66.9% in Q4 2025 from 39.9% in Q4 2024, reflecting a shift toward higher-margin software and data revenues. Operating margin improved to 30.3% from 25.5% a year ago, and net margin rose to 25.0% from 17.5%. The trailing twelve-month net income of $1.79 billion (sum of last four quarters) yields a net margin of 21.8%, well above the industry average for exchanges. This margin expansion supports the bull case that Nasdaq is successfully transitioning to a higher-margin technology business model.

Nasdaq's balance sheet is healthy but carries moderate leverage. Debt-to-equity stands at 0.81, and the current ratio is 1.01, indicating adequate short-term liquidity. Free cash flow for Q4 2025 was $536 million, and trailing twelve-month free cash flow reached $1.99 billion, implying a free cash flow yield of approximately 3.6% based on the current market cap of $55.4 billion. Return on equity (ROE) is 14.6%, and return on assets (ROA) is 5.6%, both respectable for a financial services firm. The company generates sufficient cash to cover dividends (payout ratio of 33.6%) and fund acquisitions, though it has relied on debt for large deals like Adenza. Overall, the balance sheet supports continued investment in growth without excessive risk.

Quarterly Revenue

$2.1B

2025-12

Revenue YoY Growth

+2.5%

YoY Comparison

Gross Margin

66.9%

Latest Quarter

Free Cash Flow

$2.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Capital Access Platforms
Market Technology
Market Services

Open an Account, get $2 TSLA now!

Valuation Analysis: Is NDAQ Overvalued?

Since net income is positive ($519 million in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E is 31.0x, while the forward P/E is 19.8x, based on estimated EPS of $6.05 for 2026. The wide gap between trailing and forward P/E implies the market expects significant earnings growth in the coming year, likely driven by margin expansion and cost synergies from acquisitions. The PEG ratio of 0.51 suggests the stock is undervalued relative to its expected earnings growth rate, but this depends on the accuracy of growth estimates.

Compared to industry peers, Nasdaq trades at a premium. The trailing P/E of 31.0x is above the financial data and exchanges sector average of approximately 22x (based on industry data), representing a 41% premium. This premium may be justified by Nasdaq's higher net margin (21.8% vs. industry average of ~15%) and its faster-growing fintech segment. However, the forward P/E of 19.8x is closer to the sector average, suggesting that the market is pricing in the expected earnings growth. The EV/EBITDA multiple of 20.6x is also elevated relative to the sector median of around 15x, indicating a premium valuation.

Historically, Nasdaq's trailing P/E has ranged from 20x to 40x over the past five years. The current 31.0x is near the middle of this range, suggesting it is not at extreme levels. The price-to-book ratio of 4.5x is above the historical average of 3.5x, reflecting the market's willingness to pay a premium for Nasdaq's intangible assets and brand. Overall, the valuation appears fair given the company's growth prospects and margin profile, but it leaves limited room for error if growth disappoints.

PE

31.0x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 20x~40x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

20.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Nasdaq's revenue growth deceleration to 2.5% in 2025 from double-digit rates is a primary concern, as it suggests the core exchange business may be maturing while the fintech segment has not yet scaled sufficiently to drive overall growth. The company carries moderate leverage with a debt-to-equity ratio of 0.81, and while free cash flow of $1.99 billion is healthy, the reliance on debt for acquisitions (e.g., Adenza) could become burdensome if interest rates remain elevated. Additionally, the net margin of 21.8%, while strong, is heavily dependent on the successful integration of acquired businesses and the realization of cost synergies. Market & Competitive Risks: Nasdaq's trailing P/E of 31.0x represents a 41% premium to the sector average, making it vulnerable to valuation compression if growth disappoints or if the market rotates away from growth stocks. The stock's beta of 0.997 indicates it moves in line with the market, offering no downside protection during broad sell-offs. Competitive threats include alternative trading systems, increased regulatory scrutiny on exchange fees, and the risk that fintech competitors erode market share in the software segment. Recent news about SEC approval of tokenized settlement is a positive catalyst, but regulatory uncertainty around digital assets remains a headwind. Worst-Case Scenario: A perfect storm of continued revenue deceleration, failure to integrate acquisitions, and a broad market downturn could drive the stock to its 52-week low of $76.55, representing a 13.1% decline from the current price of $88.08. In a more severe scenario, if the company issues a negative guidance revision and analysts cut targets, the stock could fall to the analyst low target of approximately $115.60 (based on low EPS estimate), but that is above current price; a more realistic worst case is a 20% decline to around $70, based on historical max drawdown of 23.9% from the 52-week high. An investor could lose up to 20-25% in an adverse scenario, with the 52-week low of $76.55 representing a 13.1% downside from current levels.

FAQ

The primary risk is revenue growth deceleration, which fell to 2.5% in 2025 from double-digit rates, threatening the growth narrative. Second, the premium valuation (trailing P/E 31.0x vs. sector 22x) makes the stock vulnerable to multiple compression if earnings disappoint. Third, integration risks from acquisitions like Verafin and Adenza could delay margin expansion or lead to write-downs. Fourth, macro risks include a potential recession reducing trading volumes and IPO activity, with the stock's beta of 0.997 offering no downside protection. The most severe risk is a combination of these factors driving the stock to its 52-week low of $76.55, a 13.1% decline from current levels.

The 12-month outlook is cautiously bullish. The base case (50% probability) sees the stock trading in the $105-$115 range, driven by steady 3-5% revenue growth and stable margins. The bull case (30% probability) targets $115-$125, fueled by successful innovation catalysts like tokenization and high-profile IPOs. The bear case (20% probability) sees the stock falling to $77-$88 if revenue growth stalls below 2%. The most likely scenario is the base case, with the stock reaching the analyst average target of $119.79, implying 36% upside. Key assumptions include sustained margin expansion and no major macroeconomic shocks.

NDAQ's trailing P/E of 31.0x is above the sector average of 22x, suggesting a premium valuation. However, the forward P/E of 19.8x is much closer to the sector, reflecting expected earnings growth of 57% from trailing EPS of $4.60 to forward EPS of $6.05. The PEG ratio of 0.51 indicates the stock is undervalued relative to its growth rate. Compared to its own history, the trailing P/E is near the middle of its 5-year range of 20x-40x. Overall, the valuation appears fair given the company's margin profile and growth prospects, but it leaves limited room for error if growth disappoints.

From a risk/reward perspective, NDAQ appears attractive at current levels. The stock trades at a forward P/E of 19.8x, which is near the sector average, and a PEG ratio of 0.51 suggests it is undervalued relative to its expected earnings growth. Analyst targets imply 36% upside to $119.79, and the company generates strong free cash flow of $1.99 billion. However, the biggest downside risk is continued revenue deceleration, which could compress the multiple. For long-term investors with a 3-5 year horizon, NDAQ is a good buy given its margin expansion and innovation catalysts. Short-term traders should be cautious due to the stock's recent volatility and underperformance versus the S&P 500.

NDAQ is better suited for long-term investment due to its transformation story and consistent dividend payments. The stock's beta of 0.997 indicates market-like volatility, making it less attractive for short-term trading. With a dividend yield of 1.08% and a payout ratio of 33.6%, it offers some income. The recommended minimum holding period is 3-5 years to allow the fintech transformation to fully materialize and for revenue growth to re-accelerate. Short-term traders may find opportunities around earnings announcements or IPO catalysts, but the stock's recent underperformance and technical resistance at $101.79 suggest limited upside in the near term.